HAE - Earnings call transcript Q1 2019 | Haemonetics Corporation

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Abrupt start. Conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] And as a reminder, today's conference call is being recorded. turn Relations. over to Vice Gerry like Investor President, now the to conference Gould, I'd ahead. go Please

Gerry Gould

Thank you, and our note Thank CEO; of quarter forward-looking today good our morning. include Chris remarks Bill fiscal Haemonetics' us by Business Chad statements. 'XX today first Burke, for Blood CFO; will conference Nikel, President Center that call Simon, webcast. and joined you I'm and for President joining Please Unit.

anticipated actual may materially Our from results. results differ

business three cause Information and and Analytical tables discuss other and Today, entitled Chris results our the make included of could we will differ within Bill and information with Relations first posted materially document call. to we two results in filed release. link financial our refer in which that pages a elements to are our Additional the website. to Supplemental we SEC. will concerning we available and on to Form Tables today fiscal is factors our This tables provided filings the and We our with performance, business. guidance guidance. this take year questions. and Investor our periodic we trends will strategy, Blood Chad fiscal our highlights discuss within 'XX Then, Reduction Initiative two we information morning, markets, XXXX our X-K in Those Center our our Complexity that in will quarter and your posted reports we served

of items Consistent past and have size certain in the charge. asset fiscal line charges I by nature items charges, adjusted the costs, sealers. certain I adjusted impairment excluded of income we a like from of benchtop comparability results which XXXX In amortization the and legal gain Before we would to mention hand restructuring over call financial XXXX, excluded our depreciation, upon practice, quarters XXXX our the we'll with treatment turn impairments, In the sale excluded accelerated and Chris, results. asset the to and their and charges, SEBRA and our first financial today. related our turnaround affect we fiscal realized and about deal-related talk results expense, we of of

the of excluded we including the details same comparisons our X-K and of posted fiscal Finally, of are our to website. effects items. quarter Investor excluded tax first provided Form Further amounts period excluded fiscal been XXXX, have XXXX Relations in with

press adjusted of complete to flows, statement Our a and Chris. results. balance and summary call P&L cash release sheet over that, our a of reported I'd With reconciliations to include as well website and the like also and as turn

Christopher Simon

call. Thanks, thank you morning today's joining and Gerry. for Good

with We start are our fiscal pleased XXXX. to

attractive many in deliver to the first and achieve in that evidence plans performance superior our our is segments, dimensions performance quarter compete positions and strategies track on Our working. leading market are are on

We effort constant are reported challenged a quarter the a and drivers; Blood growth. in in were was compared $X.XX growth revenue executing global per $X.XX our TEG Plasma year's with in of and prior resilience It Center Adjusted grew as quarter. currency. market. largest X% first multi-year turnaround the two sustained In business X% more first earnings than propelled our share and pivoting and to by nearly accelerated the

plans. our to results, growth to customer our is on Turning our BU structure enabling teams execute focused

disposable continued volume. with XX% and double-digits overall up growth. with we pace liquids Disposable rising widespread future production our revenue capacity harness capacity strong We largely have bowl, Let's quarter about We've with in was additional by U.S. bottle contributing manufacturing to capabilities production and in demand. growth and Plasma. across meet second to XX% grew half volume multiple start in our order delivered 'XX of market kits fiscal collection Growth both volumes partially timing. online XX% recently increased regions to by demand. collection the We keep driven been related double-digit investing and with will customer that was the increased anticipate bring

FDA citrate quarter sterilizer sodium manufacturing for received for additional growth. an additional this and approval also line liquids an to We support

We forward manufacturing, experience of and for contracting, have streams, performed PCS customers. the integrated also programs. NexSys four have center To these with track. NexSys an our date There are and NexLynk and disposables, platform DMS, are in providing than programs FDA are moving us center several of launch more that XX,XXX the clearances work many launch engage includes enabled All to of support technical plasma on benefits conversion regulatory, PCS service. The collections. donor we with device NexSys

and First, further its device pressure functionality. experience center the the tests donor

we are how adoption. to conversions customers modify expedite technology SOPs together to their and Second, with center learning

with improved In Third, our experience. system and experience long-term have one yield, that phlebotomists, have are staff, customers quality, overall competitive The and also reflected Feedback better our in customers are value is able NexLynk back the to donors of very the proposition is a customer of to parallel productivity, NexSys as negotiations center from advancing new contracts, integrated agreements. expected positive donor signed new about and win DMS. and increased firsthand. the platform included we several which performing greater been fully

PCS typically and XX skill our and devices conversion customers conversions offer execution. planning the involves to A is center with coupled Donor during implementation preparation convert option swift thorough with first the of and complex or of proceeding and that XX for more have with NexSys to XXX coordination devices. We conversion customers. overnight. placed day a than lots requires dozen wave a center are We process

three on advance Dedicated on training by to Our work three-day closely technicians In technical these support Haemonetics throughout complete the staff Haemonetics troubleshooting. disruption external maintenance, supplemented a operations, with center to installation. of customer daily contractors run teams minimizing collections. conversion program by is the preventive two and focus device

PCS. conducted the the but the begins converted fully New and NexSys PCS devices Customer's employees then network verification to and for installation. their technicians container parallel, to we to new early to conversion next Final format, are device ship our integrated with ready In then where this enabled working NexSys donor assembled, are operation. the reopening and and NexSys a is day to inspected center. a plasma devices is update PCS for well. prior NexLynk implementing device It centers is are used create return Customer training operator old The software days, the with is upgrades optimal the The customer for center. parameters, tested, The to views, work systems. collection appropriate staged and is decontamination perform solution. for data screen immediately shipped devices configured removal. return process are packed operational and to The to calibrated DMS installation. process

our go fact, with platform our new volume on first In ever. live its the customer commercial had day largest

wrapping in to conversion we seamlessly device our are up our ability We the capability. and rollout confident are center

manufactured to have all anticipation In a four planned. We our our date needed us gives in contracting engaged of in NexSys all second deliver confidence of across demand successful streams device as to meet have devices launch customer manufacturer. we to continued our ability work contracted and summary, experience

momentum X%. performance the hospital TEG to creating XX% in first the the started XX% We growth BUs and growth robust TEG investments time as saw in strong U.S. our Hemostasis the this and ongoing international growing Moving real and consists hospital markets. believe both year is business, performance we are capital sales. of XX% growth international. increase in disposable success included Management's domestic our increased

customize clinicians software X.X solution our access extensions easy launched product in TEG Our the with guidance line hospital feature new Manager quarter. two interpretation Saver which hospital's transfer Cell business system. blood test Elite gives called and to data to the a module a Saver messages EMR clinical enables salvage that Cell information of and solution procedure and from device alert our connectivity the

our R&D in continuing Overall, strategies are evidence build expand to we encouraged and of our starting hold. portfolio. We hospital in technologies are our invest to geographies key take are tailored by elements in for our and go-to-market to performance in critical product

must for bakeries to forward unevenness the disposables. Our robust hospital are continue are us the demand the manage product we launches of global and cycles. buying and capital propelling But capital and customers' we our to seeing his resulting was is in who and Chad the turn team improvement call Unit. runs Business Center now promoted of performance. recognition progress stabilize President to I'll the over to making Blood recently Chad Nikel

Chad Nikel

provide role that to we flatter asset today is blood XXXX Haemonetics of and the on around progress Thank update a serve the completed implementing for I'd the stability and we that to stable like achieving value that an the we creates collector Unit, layers the have In manufacturing company. globe. we made a a and the removed it our teams. aligned in with you, our Blood Center business' our commercial fiscal the within Chris. within organization reflects the for Today process management we strategy and of of customers In Business have reliable be reorganization goal

We the structure. and of reducing clarity it the our and cost stabilize our make businesses We aspects are and market allowed Today, we understanding face to us products closer realities fundamentals. of by it and richer customer to the have separate the lowering we and simplify complexity a technical optimize daily. this

affecting an portfolio SKU products available have First, operations. customers' our we in further more embarked an eye a for complexity to standardization reduction sale, baseline reduce Starting commercial program. a on an products without than effort we towards XXX XXXX with of with now of

successfully we America. is best in of extension suboptimal heightened indirect with that outcome we certain moves make and in customer our have we the have up interests market. reprice is are significance continue commercial whole our with shore necessary, One not execution contract did businesses and network value. ensuring of to working focus in in we contracts business our progress improved business the and it serve Next negotiated touch made to distribution the evaluated in our that of blood our each to results shareholders. optimizing arrangements where North largest calls These we markets that In partners pricing that best

a have how the inventory than XX%. hard by these markets product obsolete We and more made excess reduced we we at supply look and to have also taken improvements

suppliers. We pooling Unfortunately, market. more we XX% kits our We goods recall than with the an of of had gains, caused focused XXXX our a also and improvement fiscal products. portfolio remedied returned issue of cost the of efficiency kits our by one our to in our late have projects on in and issue Acrodose quality at North underlying of platelet America have sold

Rico May filter be business. of medias This and our the we to site some aftermath going vigilant a resulted supply to recovery continued In forward. collection favorable it producing assets long-term decommissioning to quality However, will highlights of focused exceptional in programs cost our for management need in Puerto the whose case was not plans oversight. Maria enhance for the remain XXXX in entered across the our at that certain Fajardo, Hurricane agreement blood stabilize This filters this allow ongoing supplier of on our our industry. best-in-class a further into in are

and investments returns continue We make have that to short business high quality payback in periods. deliberate both the

the minus to slow decline ensuring the these example, protocol million platelet For and platelet in dose Japan and of stability delivered launch X%. of universal stabilize quarter customer efforts our further These continued recent and of in in to key the rate a our technology of markets. largest first best by our provide at XXXX available Through our $XX helped the protocol, revenue relationships, business release China. both and of in these double the moves is fiscal decline customer in year-over-year we

fiscal from XXXX While now fiscal in goal And I'll our furthers timing, to turn XXXX. and back a a decline of we performance decline X.X% work over XX% quarter's following in this decline rate Chris. benefited it mid-single-digit

Christopher Simon

on key At growth. our Chad. Thanks accelerate are in focused level the addition product a launches we areas that will enterprise support to few

be an base way reducing Our processes. as up important we work cost our growth and free fund changed to in the efficiency complexity of resources reduction our factor initiative to the continues to improve

run plan of critical to run operating rate track the deliver XX. performance, quality, million in Improving on savings $XX supply annual $XX fiscal by an XXXX of including are end our rate of fiscal a to growth. excess and exiting million at product We are

remain. challenges We have efficiency made in progress but improving our operating

We disposables, in Jesep XX-year-career led Supply Manufacturing devices Llorens Josep real join are his later pleased over Chain. businesses Global equipment, turnarounds this announce Senior and consumer as and and Healthcare President, will Haemonetics to across Vice has depth brings Global and that numerous software. month capital

commercial excellence is mentioned As our contributor momentum. major a earlier, to

on excellence Given and globally quality our the our our confidence premiums value we contracting customers. product and our delivery, command in are price improving conveyed service based improve appropriate sales to challenging teams to

to refinancing, support the retain our fund Investment into recently further accelerated debt and resources thoughtful allocation develop, which and heading we We launches, is continue by agenda, accelerate to innovation our enabled and we announced to flexibility positioned closing to needed plans the with ensures growth product growth. talent. have are In capital drive attract, quarter. invest well second our

our and sustaining on and confident are to you. we we execution. XXXX affirming capabilities guidance. energy focus Our Thank fiscal building Therefore, I'm team's and in our our committed are momentum. remain driving

Now I'll turn to call over Bill. the

William Burke

refer Thank I you, posted earnings to included constant my and of continued provided XX.X% everyone. on that All in performance including and and X.X% experienced NexSys XXXX. derive rates will XXXX revenue link revenue that good fiscal attributable to product reported XX% about Strong the for anticipated of XX% higher We a in software total that in had results benefits comments. timing that growth first growth. market historical to basis income Please important much X.X% note in to quarter Chris dollar two with strong our discuss fiscal in in amount the Plasma release. we we our are and Plasma grew to quarter. North certain favorable morning liquid as in we website XXX America first incremental specific smaller refer growth I of and is to We rates. growth tables percentages basis or XX.X% solutions. currency. our revenue the It of the plasma disposables rates no accounts points growth quarter growth quarter will order revenue realized in in categories, customer than currency first grew growth from In the first revenue pricing plasma was and in disposables contributed two business the which

first year. to plasma be the growth of We NexLynk with our X.X% business benefit in comparison our plasma that the confident revenue to the of a revenue customer in investment due America, demand grew underlying of continued percentage the quarter Xs declined potential had Hemostasis over business growth first provided is of North in continues processing buy our anticipated note, quarter. and Hospital in which quarter allocation annualizing TEG EMEA. rates These for TEG Management guidance. Software derived demonstrating or our XX% growth increases by China prior-year markets Liquid quarter, XXXX double-digit plasma the low were end plasma first reflects XXXX. XXXX. in validates the meaningful in based market the growth in fiscal collection of the driven year Hemostasis within strong XX.X% revenue acceleration Also commercial broad rollout Management growth including market the and easy of remain modest quarter. in above was fiscal X.X% by past the Cell hospital near is largest the biopharmaceuticals. price achieved centers had revenue geographically a its software each teens XXXX. all This funding key first to growth. our We and of growth spot growth. low customer solutions the first across revenue towards in increases TEG's that fiscal grew an XXXX

customers. our by of year communicated declined quarter products revenue commercialization Blood Excluding our disposables, XXXX. wend fiscal the to first Cell quarter. X.X% has first been and in X.X% in declined revenue Center will this the OrthoPAT Processing fiscal

longer production margin our continued and business, declines prior to related liquid compared other in our This the first of X% and delays solution favorable U.S. the quarter, the business quarter product equipment blood, years. below the expansion. first assets decline included against XXX had met particularly of period, that savings, All points objectives. previous in declined moderation was cells, gross no is to outside from basis mix, basis also comparison whole Complexity in this gross deeper elements points costs XXX in strategic margin profitability of XX.X% software decline Blood Adjusted up the prior-year following platelets, prior-year. to the contributed quarter. year's Center reduction mostly red a demonstrated While low fiscal and

currency. Additionally, with the or expenses favorable XXXX. X.X% benefit approximately XXX of first fiscal basis increased points the were Adjusted million quarter of to compared due $X.X operating

compensation aimed decreased a XXX offsetting However, were Productivity of investments growth stock-based reductions. quarter in XXXX. this this we first than open revenue yielded anticipated operating planned expenses benefits. mitigated complexity leverage. $X future certain as G&A accelerating including reduction operating basis revenue as cost by fiscal in R&D was R&D one-time higher percentage the to Increased points quarter Partly XX.X% benefited was SG&A. benefit of gains from by and investment and from in million at positions initiatives spending planned

revenue quarter was we higher margin in and favorable of freight increased points from rates. operating an up and investments benefits prior Adjusted currency as the Complexity the higher outpaced first improved compared shipping basis of and mix, Initiative from resulting expense revenue, costs. freight Additionally, increase product had XX.X% the Reduction year reductions to volumes rising cost of XXX our

continued of Our of ’XX due rate income to the than the This the on quarter favorable tax mix. is fiscal tax the in tax first quarter significantly recent earnings XX.X% in impact first of lower U.S. provision adjusted geographic prior the XX% was year. income reform lower and

of employee immediately purposes. we related in share ’XX Additionally, benefit the a of tax for a [ph] high vestings deductible fiscal to which nearly recent point were first had X quarter level percentage

from the benefits favorable as rate $X.XX compared most This the $X.XX tax and First in impairments quarter. the as business on Blood prior and period. currency. asset Center of tax fiscal the including currency include that million the $X.XX compared about approximately first We of were fiscal the asset ’XX Chad ’XX believe adjusted earnings of product benefits incurred impairment year per unique line totaling to we from accelerated $XX $XX $X.XX prior to the share quarter $X.XX year in increase of depreciation rate costs In to lower million a first in non-strategic noted.

quarter $XX earnings. $X turnaround restructuring incurred and million also ’XX our and Free fiscal in were with in $XX first quarter with million in to inventory expenses, $X to we cost the fiscal ’XX. $XX had by quarter of ’XX. in million the incurred and $XX $XX depreciation expenses million million adjusted of approximately excluded quarter capital first devices was for fiscal restructuring before of in including first fiscal the first our anticipated These along of ’XX We of turnaround capacity of and cash incurred cash the Complexity Cumulatively, compared and Plasma in Initiative. investment in the of flow greater We first business. turnaround ’XX from Reduction expenses of NexSys of including disposables the impairments expenditures PCS approximately the the fiscal compared ’XX restructuring production fiscal have amounts the of quarter million accelerated expansion million

quarter share first the of we subsequent and under repurchase period completed an the accelerated through million $XX X, million fiscal During August authorization. ’XX our $XXX

a of $XX common cost the an of we repurchased about million average in completed six during this X.X and our million program shares have As approximately XXXX, of a been repurchase previous past $XXX months. result May at

benefit. compensation While share programs is repurchase from the the addressing dilution existing further offsetting based program is dilution recent share

nine year reflective following caused $XXX $X.XX of us to guidance. lenders completed of takes previously the depending have a of a a rates the the rate guidance. confidence single million on first the Plasma device of facilities believe of that first provided X.XX% to enhances of new through results is quarter adjusted we Combined and quarter million first LIBOR experienced During million In data loan. loan refinancing the of from growth on It's covenants. in credit point, fiscal than ’XX We issued market We full at and quarter we a growth ratio per I PCS XXXX. effective the our end loan anticipated our historical fiscal and that $XXX full than a revenue higher proceeds revenue debt of fiscal we X.XXX% in are and early of were The the the our term over executed revolving net us growth or of implied NexSys $XXX utilized X.XX% million X.X% explained execute increase We this strong enhance Certainly as growth with quarter. an do ’XX new of and the the the then ability lower plans. support June end. Interest Plasma earnings reasons proceeds a ’XX rate quarter first fiscal consider cash plus quarter cash expected earlier. our on profile balance X% our agreement year ease term of mid year new hand, with an for received million too available from but we new $XXX to on financing first to outstanding and former rate our share leverage at and flow, 'XX of credit ’XX fiscal These for million not only to our finished five-year purposes. raising a so to repay months reasons financial with $XX and remaining corporate our XX%. quarter for to strong for became our growth confirming our was general acknowledge the $XX full launch the would guidance be

remainder level We and commercialization our communicated We full the NexLynk investments planned not open very year quarter spending our in of stage. expect first the early investments and the anticipated positions. to achieve originally and did in levels NexSys have a of we to the fiscal also considered that in PCS increase including reach is

this the costs well as rollout two of PCS fiscal rising incur of collection, the expect first PCS the than unit will and In as we the of remainder impact of Plasma devices. continue. our business disposition in freight of as repositioning, We a year to quarter, devices commodity and NexSys higher expenses result also the in

Our cost guidance expenses. devices deployment NexSys the and contemplates depreciation initial related rollout PCS and of

later out also as Our for operating refinancing a result Higher a foreign studies. tax of will year but hospital some business had The the Also and on based China ’XX. which in product sales this we not rate year. in health free tariffs clinical expenses of of impact year. exchange sales and we affect fiscal build and exchange all revenue our from no force Hospital requires compared factors, interest guidance year had the continue recent trade Based elements expansion expense these continued of for the U.S. foreign rates. in debt our investment current for prior remainder flow benefit quarter, the in first higher in earnings are the the China and expected a the our to the affirmed fiscal may first of adjusted economics of on quarter cash and

to throughout in Our for The XX% to growth more benefit in double-digit the growth growth including an remainder North is fiscal growth ’XX will basis and revenue XX% occur of up pronounced Plasma Hemostasis commercial fiscal growth Management. We at in year firmed expectations affirm of much ’XX. annualized America. revenue to to in ramp the hospital in its fiscal be on including X% X% expected XX% to the X% guidance launch of our

Our is fiscal ’XX X% decline revenue Center affirmed for of as a to guidance Blood X%.

dose collection single platelet anticipating trends. modest transfusion rates are We continued in and declines

reach as expectation $X.XX million well run our the earnings long per to complexity track of strategy. to intent from our of acceleration Initiatives our rate growth a significant savings on investments current and investments of supporting end and affirm expansion our million represent $X.XX These approximately Complexity are our and Reduction of with share funded to year, $XX in enabling $XX make term and savings. the in margin realize as and at as contemplated are fiscal We to revenue excess reduction

in to mitigate costs operating affirm adjusted range benefit XX% the for gross in margin million guidance fiscal in fiscal $XX from guidance growth, ’XX NexSys PCS anticipating million at to accommodate in the manufacturing as million of XX% several ‘XX of completion Plasma as the production freight projections share per expansions cash ’XX capacity to ’XX. in the in before and restructuring to today million. ’XX devices. savings $XXX and well the margin increasing Additionally, now our We of are joining up and at other to fiscal reduction our complexity our next costs flow could years expectation million facilities appreciate expenditures fiscal $X.XX. $XX our earnings volume for adjusted $XX and of $XXX questions. affirm cash We of $X turnaround adjusted flow Capital included to fiscal you free will We proceed your range

Operator

[Operator Our CJS first Solow question comes Securities. from of Larry Instructions]

is now line Your open.

Larry Solow

in that higher conservatism it range the new to the it just the drove from NexSys question another a of I of know to have at Great, the Anything one not end thanks and would sense the no least that contributions growth that PCS there just the sort there?. Plasma recalled device. your increase sort you great guys outlook strength just and of of want questions, I and congratulations on in or two is particular you on quarter was quarter. then follow up, on rapid the

Christopher Simon

Yes, Chris. Larry it’s

latter. more We look across of I customers. the each think our it's major

good have to we've meet to We keen experienced than and certain collect quite as possible are historical first were the all Clearly they were different aspects much data as historically. that there plasma quarter of what can't a were we the the they just continue yet outstanding demands while their they'll through markets, year. quarter the the for duration we make of end in first call that that things some saw but

Larry Solow

of going is, began assume since on that confirm I depreciation guess you although of was accelerated guess will and your I going that forward? guess can of you placed you guess out I accelerated that pulled the be I to I this followup, had pulled question EPS then they adjusted depreciation any and forward just be quarter. were guess on a didn’t because revenue the I it machines out Okay those you I during noticed part just depreciate book some

William Burke

question. that for Thanks Bill. it’s Larry, So

accelerated that not relates depreciation the the the X new On devices device. PCS to

Larry Solow

Okay.

William Burke

happens what it's a let’s it has see two there associated passed device is life years that as remaining device, years. of if with only five a remaining. out two is on years if had say and that device originally the the So seven particular years, depreciation single is, We’ve made determination it

the three left that of a that between life. deprecating if been new years and what would it accelerated at we’ve we’ve depreciation depreciation seven-year difference we have deprecation the taken So and normal

Larry Solow

not adjusted new will Understood, will pull deprecation be, out? you not so not out, be PCS will in the that that

William Burke

the as we investment of spending part call That’s it.

Larry Solow

Great, Correct, that got thanks. appreciate clarification. I it.

William Burke

your question quarter is do And answer it and about of we part the C will was yes. the every

Larry Solow

Thanks. Right.

Operator

Thank you. of Petrone our next Anthony And comes Jefferies. from question

Your now line open. is

Anthony Petrone

Congratulations of couple on strong one but so customer also quarter. the a on purchases May quarter and schedule, a good maybe know of spoke ahead just Thanks. in restructuring, Chris, on you volumes. Plasma be

rest volumes? of the So sense followup, how just we thanks. trying the the rollout, up quarter, in the And get have from it of excess the already quarter a systems much trying be to as a expecting fiscal just then cadence I’ll mean, should cadence XXX to get purchases NexSys, a a then on just came And in versus sense the would follow the of be installed. you I of mentioned what rollout year? relates for to a there

Christopher Simon

thanks Anthony. Yes,

their that we to lot don't all buying on that to was see meet anything growth the anybody of in and a So have doing customers as rise and place current now other marketplace of demand our major challenge. to believe demand organic any that the meet seeing the right expectations. reason quarter we There's we're than first all

the it think consumed was we in So organic quarter. and

As the no pricing associated there mentioned the NexSys in Bill quarter. remarks, with prepared on was

we the rollout as actual that guidance. in We year, the planned, feel major fully meeting rollouts is proceeding and good through keep work being I that's center success have two with guidance we're we four affirmed the contemplated have we begun and confidence pace have streams, said as a in of in them. initial can earnest degree year, conversion why contracting of initial of and high our but the but that which terms we are for track on In we which

Anthony Petrone

be on maybe would Thanks of referenced the savings additional amount today, positive just terms there? is going what bit also company annualized a fiscal just for color then savings up the And follow again. for expectations where pretax is update you then a just, the contracting and with the level maybe exiting little the forward in high customers restructuring and ’XX? initiatives, pretax of expectation Helpful

Christopher Simon

second Okay, restructuring. thank you. let answer I'll and take regarding the first the part Bill

folks programs in terms the we of on, about It customer at the remarks positive chance In for going dialogue the have really we the the to be talked experience that quite gives contracts reasons proposition the mentioned. to continue we the move that’s get conversions, new firsthand, signed move and its device at center floor and to prepared the helped us it's when installation. to quickly experience value collection us, helped really

expected the I is reflected positive very device the all in we're again, So dialogues think and performing and what's as that's having. that

William Burke

of guess than exactly Anthony year said there. we’re said Anthony, Oh that I this I We're a XX ‘XX by so the time. a Bill. we just right at we’re On would sorry, the quarter fiscal of XX million. for still was obviously end the are end see we're be not in in savings, at wrong million half this a of the will of rate going we thought what first run half. the to By by be in the $XX question, to past affirming at on where fiscal bit the hit fiscal in more the restructuring savings ’XX plan $XX we its and run Anthony, the excess will we'll the we little of we rate year where track number I disclose second be on on

Anthony Petrone

again. Thanks

Operator

comes our David of Morgan Lewis you question from Stanley. Thank next and

is now open. Your line

David Lewis

Chris, a morning. few Good questions here. just

it's is and customers will relative so The to system in first or are terms are clear how roll actively NexSys are not the out the release, roll to out rolling under system NexSys the contract contracted many your expectations? how those how out or customers many

Christopher Simon

We're DMS good going value of PCS entered not customer to the NexSys individual as are therein. software contracts We're as many had and agreements for think and the these for the and question. the discussions our and talk others They with well. I well. we've We customers confidentiality in about into. about customers competitiveness actual for our and thanks David that NexLynk reflective of themselves, increasingly really interestingly, several. And negotiations long-term feel So specifics we

the reason. we NexSys of agnostic As good for originally you'll to recall, be designed PCS DMS software

reflective And is wave writing of However, benefit experience NexSys platform customers contracts of achieve the first of their really as part the that. are we the of value to are that by the DMS upgrading proposition. this able full they're

David Lewis

Okay, it under customers is least so at NexSys rolling the that system new out contract? a three are sounds it

Christopher Simon

specific about we’re specifics to David, talk and Again going not numbers.

what are and wave and quite feeling will one about track We next. come on fully good

David Lewis

through but Plasma obviously there the Bill, American a Okay thinking you've to XX guidance, quarter. XX% wins, you detail, guiding know new was and so about obviously customer fair and quarter, have no then XX amount first gone this North you're this I to pricing just in in some of

your North effectively, back So has that lines, American to below do of reason that just business any business year grow have grows disposable the to that half you below kind market? Plasma assume guidance reading for the would into believe market, basically of the

William Burke

rate We don't, have did QX it the to which referred XX%. drove which that to actually the we XX% in order but XX% is timing earlier, Chris growth above customer

the the of for higher is quarter total consumed we're one then but expect this that to we would So if point, pretty us comfortable. enough that just if probably We is wanted at amount as change data guidance feeling point wait a volume to rate.

David Lewis

expansion associated a margins underlying some you costs depreciation quarters say of next you've similar thinking - just plans I but question here, just you've rollout as though few headwinds it got, of in also quarter. first with solid and got is Okay kind the NexSys, same

looking to be quarter to the the any we basis, the much. margins at a reinvestment like last three the should margin spending quarters three the the lot should different or pretty to playing third out relative least there on quarter. about second unique and fourth rollout three generally how three the obviously next same way and first reason years going So next look next something sort XXX quarters the prior in relative Is significant think are by historically, quarter? we’ve is based quarters where points quarters in basis two a there believe Thanks of that before up ticked this on reasons so performance the seen they

William Burke

operating Yes, we in thanks as David. I don't much NexSys, the through expect the us from that to that margin. with we should move the we received is see dropped as Obviously that are this investments offsetting pricing benefits business year other variability that again hospital for margin but making the in terms significant investments through, the in uptick example. have rollout we that the some of and in

expect today. would So of little off overall but a margins be that not are where choppy, I far we to

David Lewis

All much. so right, thanks

Operator

Instructions] question of and [Operator comes Sidoti Thank Company. you. And next Sidoti Jim from our

Your line is now open.

Jim Sidoti

Good morning. Can me? you hear

William Burke

sir. Yes,

Jim Sidoti

great. Great,

to just do million seems First it line, new place might quarter, the been going little, think that interest question talked the up forward? new and in you will closer around call, expense, interest you with a $X $X.X like the be with it's on a that rates on the financing you’ve about put tick million it it running

William Burke

so the be balance quarter. outstanding on the the quarter year in our five of see so we than interest, have by it months last it X.XXX and first rate affective we that average will the Jim, was The you in can higher is said

Jim Sidoti

it is $X.X million million Okay, and that $X between – us a give it somewhere quarter is can you any looks to right? about me

William Burke

a be $X million. will over bit little It

Jim Sidoti

over okay. Little once right, on bit there them those you devices question is PCSX back? bring any second for market the All and X,

Christopher Simon

to typically are of certainly is in there. opportunity There what exploring then could we forward. restrictions of be have markets represent have it's used us in outside be that that North priced so the I do and them, America, going actively other don't certify we're a is There able but sizable device, we're collection Jim. including products exploring like but a not U.S. sell and the today terms global to and mean for on been are it repurposed attractive looking basis that we there's an to markets in potentially actively later that we markets base

a remember number optimistic those that So uses about excess will road, total in NexSys of conversion. we're talking we're the but XX,XXX in find cautiously devices down devices the for

Jim Sidoti

thank you. right, All

Operator

you next our Keusch Thank from and comes Raymond Larry James. question of

Your line open. is now

Larry Keusch

Good morning everyone.

its how could you're thinking issue question, just talk you about maybe going of coming the is capacity, manufacturer a the manufacturer in first you one? device your just Just hit little first it call second and about on that parallel that is through that an that referenced in bit talk is or sort to

Christopher Simon

Yes, I an on our think behalf. conservatism that's appropriate

and demand the meet full want we do to to sure have make to necessary quickly moving are We capacity that we that.

to device we parallel flexibility think demand So in redundancy, it supplier it gives our in it longstanding meet and initial I with the the as it will be us gives gives us and us ramp. short ability term

challenges driving is we I connections to as our having highly is they secondary think because face manufactures challenge probably and the helpful biggest into and supply able that are really prevent qualified chain device there market that assembly have secondary they supply two occur.

Larry Keusch

Okay, perfect perhaps and then Bill. two for

the and so in the exposure but the of spend I contemplated recognize given the just obviously, lastly, and And quantified currently just order guidance? there fairly just there Just a business, parts various quarter? you - on the tariffs if that could didn’t would you moment in you great? all be I thoughts timing dynamic, was recall sort mentioned first the any actually what of is on what's this then worth the

Christopher Simon

I'll the we America if its range growth specifically on didn't first the take the quantify take the timing so Okay order was it XX% We think that guidance that We just, Plasma what we within in out. first. quarter. time, rate North

Larry Keusch

Okay.

Christopher Simon

the And on tariffs?

William Burke

be something with understanding within dealing and Right to not now it's codes at situation. a look able fluid cover some an item type because to us what we'll Obviously is of it's would very very closely. are material that have impact it It we a business think them. of at the all, Larry. we're We the product on we have just tariff

Larry Keusch

very Thanks much. perfect. Okay,

William Burke

Okay.

Operator

remarks. no showing further turn at you the Haemonetics I'd Thank for this and I'm back to call questions like to any over time. closing

Christopher Simon

company various our our behind us Thank drives not the really is NexSys you excited you that line I the comes reduction today. for is that much growth market, but the projections. through your for extensions for this force mode, about, addition in questions bringing also TEG to what to accelerated quite on only very in and for Again, we're thank thank hope launch complexity is for our again you we're dialing and call. which and that

Operator

Ladies great a and gentlemen, thank day. may you This and conference. Everyone program you does the for disconnect. participating have in all conclude today's

Haemonetics (HAE) 7 Aug 182019 Q1 Earnings call transcript